Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis

1. Gladman, D.D.
2. Orbai, A.-M.
3. Gomez-Reino, J.
4. Chang-Douglass, S.
5. Leoncini, E.
6. Burton, H.E.
7. Kanik, K.S.
8. Romero, A.B.
9. Cappelleri, J.C.
10. Hsu, M.-A.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.CURTHERES.2020.100601 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus